Inhibition of pulmonary carcinoma proliferation or metastasis of miR-218 via down-regulating CDCP1 expression

X.-J Zeng, Y.-H Wu, M Luo, P.-G Cong, H Yu, Xiangjun Zeng
unpublished
pression was suppressed by miR-218 over-expression (p<0.05 compared to control group). CONCLUSIONS: MiR-218 inhibits NSCLC proliferation or metastasis via down-regulating CD-CP1, and can work as one novel molecular target for lung cancer diagnosis.
fatcat:wcqqxoevk5d6levzvlelava2ga